Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy

被引:306
作者
Nazarian, S
Bluemke, DA
Lardo, AC
Zviman, MM
Watkins, SP
Dickfeld, TL
Meininger, GR
Roguin, A
Calkins, H
Tomaselli, GF
Weiss, RG
Berger, RD
Lima, JAC
Halperin, HR
机构
[1] Johns Hopkins Univ Hosp, Div Cardiol, Dept Med Cardiol, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ Hosp, Dept Radiol, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ Hosp, Dept Biomed Engn, Baltimore, MD 21287 USA
[4] Johns Hopkins Univ Hosp, Dept Surg, Baltimore, MD 21287 USA
关键词
electrophysiology; magnetic resonance imaging; tachyarrhythmias;
D O I
10.1161/CIRCULATIONAHA.105.549659
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with left ventricular dysfunction have an elevated risk of sudden cardiac death. However, the substrate for ventricular arrhythmia in patients with nonischemic cardiomyopathy remains poorly understood. We hypothesized that the distribution of scar identified by MRI is predictive of inducible ventricular tachycardia. Methods and Results: Short-axis cine steady-state free-precession and postcontrast inversion-recovery gradient-echo MRI sequences were obtained before electrophysiological study in 26 patients with nonischemic cardiomyopathy. Left ventricular ejection fraction was measured from end-diastolic and end-systolic cine images. The transmural extent of scar as a percentage of wall thickness (percent scar transmurality) in each of 12 radial sectors per slice was calculated in all myocardial slices. The percentages of sectors with 1% to 25%, 26% to 50%, 51% to 75%, and 76% to 100% scar transmurality were determined for each patient. Predominance of scar distribution involving 26% to 75% of wall thickness was significantly predictive of inducible ventricular tachycardia and remained independently predictive in the multivariable model after adjustment for left ventricular ejection fraction (odds ratio, 9.125; P = 0.020). Conclusions: MR assessment of scar distribution can identify the substrate for inducible ventricular tachycardia and may identify high-risk patients with nonischemic cardiomyopathy currently missed by ejection fraction criteria.
引用
收藏
页码:2821 / 2825
页数:5
相关论文
共 19 条
[1]   Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries [J].
Babu-Narayan, SV ;
Goktekin, O ;
Moon, JC ;
Broberg, CS ;
Pantely, GA ;
Pennell, DJ ;
Gatzoulis, MA ;
Kilner, PJ .
CIRCULATION, 2005, 111 (16) :2091-2098
[2]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[3]   Infarct morphology identifies patients with substrate for sustained ventricular tachycardia [J].
Bello, D ;
Fieno, DS ;
Kim, RJ ;
Pereles, S ;
Passman, R ;
Song, G ;
Kadish, AH ;
Goldberger, JJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (07) :1104-1108
[4]   DIAGNOSTIC-VALUE OF VENTRICULAR STIMULATION IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY [J].
BREMBILLAPERROT, B ;
DONETTI, J ;
DELACHAISE, AT ;
SADOUL, N ;
ALIOT, E ;
JUILLIERE, Y .
AMERICAN HEART JOURNAL, 1991, 121 (04) :1124-1131
[5]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[6]   REPERFUSED AND NONREPERFUSED MYOCARDIAL-INFARCTION - DIAGNOSTIC POTENTIAL OF GD-DTPA-ENHANCED MR IMAGING [J].
DEROOS, A ;
VANROSSUM, AC ;
VANDERWALL, E ;
POSTEMA, S ;
DOORNBOS, J ;
MATHEIJSSEN, N ;
VANDIJKMAN, PRM ;
VISSER, FC ;
VANVOORTHUISEN, AE .
RADIOLOGY, 1989, 172 (03) :717-720
[7]   ELECTROPHYSIOLOGIC ABNORMALITIES IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - A CONSECUTIVE ANALYSIS IN 155 PATIENTS [J].
FANANAPAZIR, L ;
TRACY, CM ;
LEON, MB ;
WINKLER, JB ;
CANNON, RO ;
BONOW, RO ;
MARON, BJ ;
EPSTEIN, SE .
CIRCULATION, 1989, 80 (05) :1259-1268
[8]   Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia [J].
Hsia, HH ;
Callans, DJ ;
Marchlinski, FE .
CIRCULATION, 2003, 108 (06) :704-710
[9]   The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. [J].
Kim, RJ ;
Wu, E ;
Rafael, A ;
Chen, EL ;
Parker, MA ;
Simonetti, O ;
Klocke, FJ ;
Bonow, RO ;
Judd, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1445-1453
[10]   Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol [J].
Leite, LR ;
Fenelon, G ;
Simoes, A ;
Silva, GG ;
Friedman, PA ;
De Paola, AAV .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (06) :567-573